SAN FRANCISCO, Feb. 27, 2025 (GLOBE NEWSWIRE) — On February 26, 2025, the price of AppLovin Corporation (NASDAQ:APP), a prominent software-based platform company for advertisers to enhance marketing and monetization of their content, shares tumbled $46.06 (-12%) as a result of two short seller research firms’ accusations about the company’s AI ad technology, AXON 2.0 — the source of the company’s considerable boost in ad performance and dramatic increase in the number of installs.
Hagens Berman is investigating the possible misconduct and urges investors who purchased AppLovin shares and suffered substantial losses to submit your losses now.
Visit: www.hbsslaw.com/investor-fraud/app
Contact the Firm Now: APP@hbsslaw.com
844-916-0895
AppLovin Corporation (APP) Investigation:
AppLovin has repeatedly touted AXON 2.0 as “the best and fastest-growing product we’ve ever released.”
The investigation is focused on whether the company may have improperly withheld crucial information from investors about what AXON 2.0 actually does and the manner in which it has driven revenue growth.
By February 26, 2025, AppLovin’s claims about the sources of its growth came under investor scrutiny after Fuzzy Panda Research and Culper Research published adverse research reports about the company, both raising serious concerns about whether AppLovin has been misrepresenting investors about Axon 2.0.
More specifically, …
